A Study of Imlunestrant (LY3484356) in Healthy Women
Clinical trial NCT05509816 · COMPLETED
Trial details
- NCT number
- NCT05509816
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-12
- Primary completion
- 2022-11-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.